ask="0.3350"
ask_size="20000"
average_daily_volume="1558900"
bid="0.3060"
bid_size="6000"
book_value="0.1680"
change="-0.0059"
change_from_200_day_moving_average="-0.0579"
change_from_50_day_moving_average="-0.0154"
change_from_52_week_high="-0.8675"
change_From_52_week_low="0.0125"
change_in_percent="-1.9131%"
close="0.3025"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2040"
ebitda="-41.64M"
eps_estimate_current_year="-0.1300"
eps_estimate_next_quarter="-0.0300"
eps_estimate_next_year="-0.1100"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.3155"
high_52_weeks="1.1700"
last_trade_date="1/3/2017"
last_trade_price="0.3025"
last_trade_size="15000"
last_trade_time="3:59pm"
low="0.3025"
low_52_weeks="0.2900"
market_capitalization="77.79M"
moving_average_200_day="0.3604"
moving_average_50_day="0.3179"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.2500"
open="0.3100"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-16.0743%"
percent_change_from_50_day_moving_average="-4.8380%"
percent_change_from_52_week_high="-74.1453%"
percent_change_from_52_week_low="+4.3104%"
previous_close="0.3084"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.8357"
price_per_sales="1.4559"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.5700"
stock_exchange="NCM"
symbol="PPHM"
volume="1516701"
weeks_range_52="0.2900 - 1.1700"
